Insights into the broad cellular effects of nelfinavir and the HIV protease inhibitors supporting their role in cancer treatment and prevention
出版年份 2013 全文链接
标题
Insights into the broad cellular effects of nelfinavir and the HIV protease inhibitors supporting their role in cancer treatment and prevention
作者
关键词
-
出版物
CURRENT OPINION IN ONCOLOGY
Volume 25, Issue 5, Pages 495-502
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2013-07-19
DOI
10.1097/cco.0b013e328363dfee
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway
- (2013) Howard A. Burris CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Autophagy in Human Health and Disease
- (2013) Augustine M.K. Choi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance
- (2013) M Kraus et al. Blood Cancer Journal
- ER stress activates lytic gene expression in KSHV-associated tumor cell lines
- (2013) Nene Kalu et al. Infectious Agents and Cancer
- Targeting endoplasmic reticulum signaling pathways in cancer
- (2012) Fabio Martinon ACTA ONCOLOGICA
- Ritonavir or saquinavir impairs the invasion of cervical intraepithelial neoplasia cells via a reduction of MMP expression and activity
- (2012) Giovanni Barillari et al. AIDS
- Pharmacological targeting of endoplasmic reticulum stress signaling in cancer
- (2012) Axel H. Schönthal BIOCHEMICAL PHARMACOLOGY
- Phase I study of nelfinavir in liposarcoma
- (2012) Janet Pan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Preferential killing of triple-negative breast cancer cells in vitro and in vivo when pharmacological aggravators of endoplasmic reticulum stress are combined with autophagy inhibitors
- (2012) Simmy Thomas et al. CANCER LETTERS
- Akt Inhibitors MK-2206 and Nelfinavir Overcome mTOR Inhibitor Resistance in Diffuse Large B-cell Lymphoma
- (2012) A. M. Petrich et al. CLINICAL CANCER RESEARCH
- Targeting the PI3K signaling pathway in cancer therapy
- (2012) Chandra Bartholomeusz et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Nelfinavir inhibits regulated intramembrane proteolysis of sterol regulatory element binding protein-1 and activating transcription factor 6 in castration-resistant prostate cancer
- (2012) Min Guan et al. FEBS Journal
- The human immunodeficiency virus-1 protease inhibitor nelfinavir impairs proteasome activity and inhibits the proliferation of multiple myeloma cells in vitro and in vivo
- (2012) C. Bono et al. HAEMATOLOGICA
- Amprenavir inhibits the migration in human hepatocarcinoma cell and the growth of xenografts
- (2012) Vincenzo Esposito et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Antitumour effects of a protease inhibitor, nelfinavir, in hepatocellular carcinoma cancer cells
- (2012) Lihua Sun et al. JOURNAL OF CHEMOTHERAPY
- Selective Inhibition of HER2-Positive Breast Cancer Cells by the HIV Protease Inhibitor Nelfinavir
- (2012) Joong Sup Shim et al. JNCI-Journal of the National Cancer Institute
- A Phase I Trial of the HIV Protease Inhibitor Nelfinavir with Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer: A Report of Toxicities and Clinical Response
- (2012) Ramesh Rengan et al. Journal of Thoracic Oncology
- Ritonavir Interacts With Bortezomib to Enhance Protein Ubiquitination and Histone Acetylation Synergistically in Renal Cancer Cells
- (2012) Akinori Sato et al. UROLOGY
- Synergistic effects of nelfinavir and bortezomib on proteotoxic death of NSCLC and multiple myeloma cells
- (2012) S Kawabata et al. Cell Death & Disease
- Epstein-Barr virus lytic gene expression is tightly linked to ER stress but not cytotoxicity with bortezomib or nelfinavir
- (2012) Courtney M Shirley et al. Infectious Agents and Cancer
- The HIV Protease Inhibitor Nelfinavir Inhibits Kaposi's Sarcoma-Associated Herpesvirus Replication In Vitro
- (2011) Soren Gantt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Exposure to HIV-protease inhibitors selects for increased expression of P-glycoprotein (ABCB1) in Kaposi's sarcoma cells
- (2011) M B Lucia et al. BRITISH JOURNAL OF CANCER
- Nelfinavir induces radiation sensitization in pituitary adenoma cells
- (2011) Jing Zeng et al. CANCER BIOLOGY & THERAPY
- Nelfinavir Induces Liposarcoma Apoptosis through Inhibition of Regulated Intramembrane Proteolysis of SREBP-1 and ATF6
- (2011) M. Guan et al. CLINICAL CANCER RESEARCH
- Bortezomib Targets the Caspase-Like Proteasome Activity in Cervical Cancer Cells, Triggering Apoptosis That Can be Enhanced by Nelfinavir
- (2011) A. Bruning et al. CURRENT CANCER DRUG TARGETS
- Human herpesvirus 8-associated neoplasms
- (2011) Soren Gantt et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Modulation of CCAAT/Enhancer Binding Protein Homologous Protein (CHOP)-dependent DR5 Expression by Nelfinavir Sensitizes Glioblastoma Multiforme Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)
- (2011) Xiaobing Tian et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Human Immunodeficiency Virus Protease Inhibitor Ritonavir Inhibits Lung Cancer Cells, in Part, by Inhibition of Survivin
- (2011) Anjaiah Srirangam et al. Journal of Thoracic Oncology
- Drug Discovery Using Chemical Systems Biology: Weak Inhibition of Multiple Kinases May Contribute to the Anti-Cancer Effect of Nelfinavir
- (2011) Li Xie et al. PLoS Computational Biology
- Validation and toxicity of PI3K/Akt pathway inhibition by HIV protease inhibitors in humans
- (2010) John P. Plastaras et al. CANCER BIOLOGY & THERAPY
- KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine
- (2010) Don Ganem JOURNAL OF CLINICAL INVESTIGATION
- The effect of HAART in 254 consecutive patients with AIDS-related Kaposiʼs sarcoma
- (2009) Mark Bower et al. AIDS
- Clinical course of classic Kaposiʼs sarcoma in HIV-negative patients treated with the HIV protease inhibitor indinavir
- (2009) Paolo Monini et al. AIDS
- The Impact of Nelfinavir Exposure on Cancer Development Among a Large Cohort of HIV-Infected Patients
- (2009) Nancy F Crum-Cianflone et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- An HIV protease inhibitor, ritonavir targets the nuclear factor-kappaB and inhibits the tumor growth and infiltration of EBV-positive lymphoblastoid B cells
- (2008) Md. Zahidunnabi Dewan et al. INTERNATIONAL JOURNAL OF CANCER
- Phase I Trial of the Human Immunodeficiency Virus Protease Inhibitor Nelfinavir and Chemoradiation for Locally Advanced Pancreatic Cancer
- (2008) Thomas B. Brunner et al. JOURNAL OF CLINICAL ONCOLOGY
- Ritonavir induces endoplasmic reticulum stress and sensitizes sarcoma cells toward bortezomib-induced apoptosis
- (2008) M. Kraus et al. MOLECULAR CANCER THERAPEUTICS
- Repositioning HIV protease inhibitors as cancer therapeutics
- (2008) Wendy B Bernstein et al. Current Opinion in HIV and AIDS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started